Skip to main content
. Author manuscript; available in PMC: 2021 Dec 1.
Published in final edited form as: Laryngoscope. 2020 Jan 6;130(12):E773–E781. doi: 10.1002/lary.28493

Fig. 2.

Fig. 2.

BPTES inhibits iLTS scar fibroblast proliferation. (A) BPTES attenuates iLTS scar fibroblasts proliferation at 24 hours compared to untreated iLTS scar fibroblasts in MTS proliferation assay. (B) Proliferation rate is reported on a per-subject basis. **P < .01. BPTES = bis-2-(5-phenylacetamido-1,3,4-thiadiazol-2-yl) ethyl sulfide.